PALI Exercise Disclosure
Finley John David · SEC Form 4 · Filed Oct 7, 2026
Exercise
Reported value range
Not reported
Finley John David CEO CFO
PALI
Palisade Bio, Inc.
PALI
Transaction date
Oct 6, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 1 day later
PALI daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,227,384 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-046201
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$2.1M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Palisade Bio, Inc. PALI | Exercise | Oct 6, 2026 | $0 |
| Palisade Bio, Inc. PALI | Exercise | Oct 6, 2026 | $0 |
| Palisade Bio, Inc. PALI Current | Exercise | Oct 6, 2026 | Not reported |
| Palisade Bio, Inc. PALI | Disposition | Oct 6, 2026 | $2.1M |